Perispinal etanercept: Potential as an Alzheimer therapeutic

por Griffin, W Sue T
Publicado 2008

Alzheimer's - Looking beyond plaques

por Griffin, W. Sue T.
Publicado 2011

Silver Staining of Alzheimer's Disease

por Aboud, Orwa, Griffin W, Sue T.
Publicado 2014

Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease

por Mrak, Robert E, Griffin, W Sue T
Publicado 2007

Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis

por Wilcock, Donna M, Griffin, W Sue T
Publicado 2013

Welcome to the Journal of Neuroinflammation!

por Mrak, Robert E, Griffin, W Sue T
Publicado 2004

Funding free and universal access to Journal of Neuroinflammation

por Mrak, Robert E, Griffin, W Sue T
Publicado 2004

Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease

por Thal, Dietmar Rudolf, Griffin, W Sue T, Braak, Heiko
Publicado 2008

The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective

por Shaftel, Solomon S, Griffin, W Sue T, O'Banion, M Kerry
Publicado 2008

Microglia and neuroinflammation: a pathological perspective

por Streit, Wolfgang J, Mrak, Robert E, Griffin, W Sue T
Publicado 2004

Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype

por Aboud, Orwa, Mrak, Robert E, Boop, Frederick A, Griffin, W Sue T
Publicado 2013

Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactofe...

por Nara, Peter L., Sindelar, Daniel, Penn, Marc S., Potempa, Jan, Griffin, W. Sue T.
Publicado 2021

Interleukin-1 mediates Alzheimer and Lewy body pathologies

por Griffin, W Sue T, Liu, Ling, Li, Yuekui, Mrak, Robert E, Barger, Steven W
Publicado 2006

Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease

por Ganne, Akshatha, Balasubramaniam, Meenakshisundaram, Griffin, W. Sue T., Shmookler Reis, Robert J., Ayyadevara, Srinivas
Publicado 2022

Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease

por Pey, Peixuan, Pearce, Ronald KB, Kalaitzakis, Michail E, Griffin, W Sue T, Gentleman, Steve M
Publicado 2014

Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors

por Liu, Ling, Aboud, Orwa, Jones, Richard A, Mrak, Robert E, Griffin, W Sue T, Barger, Steven W
Publicado 2011

Aging, Alzheimer's, and APOE genotype influence the expression and neuronal distribution patterns of microtubule motor protein dynactin-P50

por Aboud, Orwa, Parcon, Paul A., DeWall, K. Mark, Liu, Ling, Mrak, Robert E., Griffin, W. Sue T.
Publicado 2015

Induction of serine racemase expression and D-serine release from microglia by amyloid β-peptide

por Wu, Sheng-Zhou, Bodles, Angela M, Porter, Mandy M, Griffin, W Sue T, Basile, Anthony S, Barger, Steven W
Publicado 2004

APP-BP1 inhibits Aβ42 levels by interacting with Presenilin-1

por Chen, Yuzhi, Bodles, Angela M, McPhie, Donna L, Neve, Rachael L, Mrak, Robert E, Griffin, W Sue T
Publicado 2007

Loss of angiotensin II receptor expression in dopamine neurons in Parkinson’s disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH gua...

por Zawada, W Michael, Mrak, Robert E, Biedermann, JoAnn, Palmer, Quinton D, Gentleman, Stephen M, Aboud, Orwa, Griffin, W Sue T
Publicado 2015